Is Black Seed Oil Sleep Onset Randomized Trial safe?

Updated August 2026

Quick Answer

Black Seed Oil Sleep Onset Randomized Trial has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Staff from a UK higher education institution ( n = 28) with short sleep duration (<7 h) and elevated cardiometabolic risk were randomised to SEI or SI.

Key Takeaways

  • 01Staff from a UK higher education institution ( n = 28) with short sleep duration (<7 h) and elevated cardiometabolic risk were randomised to SEI or SI. [Du Preez A (2026)]
  • 02Workplaces offer a key setting for health improvement interventions, given their reach and potential to promote lasting behaviour change. [Du Preez A (2026)]
  • 03While diet and physical activity (PA) are common targets, sleep remains an underexplored yet influential factor in employee health. [Du Preez A (2026)]
  • 04These disturbances occur despite adequate opportunity and conditions for sleep [], and they result in general dissatisfaction with sleep quality and various daytime impairments. [&#379;e&#322;abowski Kacper (2025)]
The current Migaku evidence database contains 2 reusable source documents for Black Seed Oil Sleep Onset Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - Staff from a UK higher education institution ( n = 28) with short sleep duration (<7 h) and elevated cardiometabolic risk were randomised to SEI or SI. [Du Preez A (2026); evidence level 2] - Workplaces offer a key setting for health improvement interventions, given their reach and potential to promote lasting behaviour change. [Du Preez A (2026); evidence level 2] - While diet and physical activity (PA) are common targets, sleep remains an underexplored yet influential factor in employee health. [Du Preez A (2026); evidence level 2] - These disturbances occur despite adequate opportunity and conditions for sleep [], and they result in general dissatisfaction with sleep quality and various daytime impairments. [&#379;e&#322;abowski Kacper (2025); evidence level 3] - Individuals reporting nighttime symptoms without associated daytime dysfunction are not classified as having clinical insomnia [,]. [&#379;e&#322;abowski Kacper (2025); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Randomised feasibility trial of a remotely delivered holistic UK employee programme combining tailored sleep hygiene, diet, and physical activity counselling for weight management: a mixed-methods evaluation.
  2. The Efficacy of Melatonergic Receptor Agonists Used in Clinical Practice in Insomnia Treatment: Melatonin, Tasimelteon, Ramelteon, Agomelatine, and Selected Herbs